HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Pitt investigators to lead $15 million federal initiative to manage breathing disorder clinical trials

The University of Pittsburgh Graduate School of Public Health and School of Medicine investigators will be leading a $15 million, five-year federal initiative to manage national clinical trials aimed at developing new treatments for breathing disorders.

5 Oct 2015

Unique molecule can bind HIV-infected cells to killer T cells

A unique molecule developed at Duke Medicine, the University of North Carolina at Chapel Hill and MacroGenics, Inc., is able to bind HIV-infected cells to the immune system's killer T cells. It could become a key part of a shock-and-kill strategy being developed in the hope of one day clearing HIV infection.

29 Sep 2015

The Center for Bariatric Surgery receives MBSAQIP accreditation for safe, high-quality bariatric patient care

The Center for Bariatric Surgery has earned certification for adult and teen weight loss surgery under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) which sets standards for safe, high-quality bariatric patient care.

29 Sep 2015

Mylan releases generic version of Invega in the U.S.

Mylan N.V. today announced the U.S. launch of Paliperidone Extended-Release Tablets 1.5 mg, 3 mg, 6 mg and 9 mg, the generic version of Janssen's Invega.

28 Sep 2015

Investment in radiotherapy services could save lives, boost economy in developing countries

Millions of people are dying from potentially treatable cancers like breast and prostate because of a chronic underinvestment in radiotherapy resources, according to a major new Commission on access to radiotherapy, published in The Lancet Oncology, and being presented at the 2015 European Cancer Congress in Vienna, Austria.

26 Sep 2015

New Kaiser Permanente study finds small decline in obesity rates among young people in Southern California

A new study from Kaiser Permanente found a small but significant decline in the percentage of young people who are overweight and obese in Southern California. The decline was seen across all ages, races and ethnicities, but was less pronounced in girls, adolescents, Hispanic and black children, according to the results published today in The Journal of Pediatrics.

26 Sep 2015

TSRI scientists awarded grant from Gates Foundation to develop revolutionary alternative HIV/AIDS vaccine

Scientists from the Florida campus of The Scripps Research Institute have been awarded up to nearly $6 million dollars from the Bill & Melinda Gates Foundation to develop a revolutionary HIV/AIDS alternative vaccine that has demonstrated great potential in animal models.

23 Sep 2015

Mylan releases Fluvastatin Sodium Extended-release Tablets in the U.S.

Mylan N.V. today announced the U.S. launch of Fluvastatin Sodium Extended-release Tablets, 80 mg, which is the generic version of Novartis' Lescol XL Tablets.

18 Sep 2015

Study shows fear and stigma are major factors that contribute to spread of AIDS, Ebola

Just weeks after Sierra Leone discharged its last patient, a new study reflects on the lessons learnt from the recent outbreak of Ebola, comparing it with that of AIDS in Africa in the early 1980s.

18 Sep 2015

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Benitec Biopharma Limited, a clinical-stage biotechnology company developing innovative therapeutics based on its gene-silencing technology, DNA-directed RNA interference (ddRNAi), is pleased to announce it has initiated a new site for its ongoing Phase 1/2a TT-034 trial at the Methodist Health System Clinical Research Institute in Dallas, Texas.

16 Sep 2015

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

It is estimated that half of all cancer patients suffer from a muscle wasting syndrome called cachexia. Cancer cachexia impairs quality of life and response to therapy, which increases morbidity and mortality of cancer patients. Currently, there is no approved treatment for muscle wasting but a new study from the Research Institute of the McGill University Health Centre and University of Alberta could be a game changer for patients, improving both quality of life and longevity.

15 Sep 2015

A Day with HIV: A new initiative to tackle stigma, discrimination against HIV patients

On one day, Tuesday, September 22nd, Positively Aware and TPAN are inviting everyone, regardless of HIV status, to get in the picture and participate in A Day with HIV, the magazine's sixth annual anti-stigma photo campaign. On 9/22/2015 people across the world, whether HIV-positive or negative, will visually capture and share a moment of their day – A Day with HIV – to focus attention on what it means to live in a world with HIV.

14 Sep 2015

UNITAID, EGPAF launch new initiative to scale up HIV diagnosis among newborns in African countries

UNITAID and the Elizabeth Glaser Pediatric AIDS Foundation today launched an initiative that will dramatically scale up HIV diagnosis among newborns in nine African countries. In partnership with ministries of health, this initiative will make "point-of-care" testing more widely available to HIV-exposed infants early in their lives, when they are most at risk of dying, and enable those diagnosed with the virus to be put on lifesaving treatment more quickly.

14 Sep 2015

A growing number of deaths attributed to avoidable risk factors

A wide range of avoidable risk factors to health – ranging from air pollution to poor diets to unsafe water – account for a growing number of deaths and a significant amount of disease burden, according to a new analysis of 79 risks in 188 countries.

11 Sep 2015

High blood pressure, smoking, and poor dietary habits are greatest risk factors for death

A huge international study of global causes of death has revealed that since 1990, there has been a profound change in risk factors for death.

11 Sep 2015

Psychosis, hepatitis C infection are greatest risk factors for mortality in marginalized Vancouver residents

Marginalized residents of Vancouver's Downtown Eastside are dying at more than eight times the national average, and treatable conditions are the greatest risk factors for mortality, researchers at the University of British Columbia have found.

11 Sep 2015

Three drug-like compounds may offer better odds of survival to patients with prostate cancer, find SMU researchers

Researchers at Southern Methodist University, Dallas, have discovered three new drug-like compounds that could ultimately offer better odds of survival to prostate cancer patients.

9 Sep 2015

Mylan releases generic version of Yasmin Tablets in the U.S.

Mylan N.V. today announced the U.S. launch of Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.03 mg, which is the generic version of Bayer's Yasmin Tablets. Mylan's partner Famy Care Ltd. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for use by women to prevent pregnancy.

8 Sep 2015

Cipla enters into definitive agreements to acquire two US-based companies

Cipla, a global pharmaceutical company which uses technology and innovation to meet the everyday needs of all patients, today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.

4 Sep 2015

World leaders meet at World Hepatitis Summit to discuss prevention strategies for viral hepatitis

Today marks the start of the first-ever World Hepatitis Summit hosted in Glasgow, Scotland, at the Scottish Exhibition and Conference Centre.

3 Sep 2015

HIV/AIDS News and Research

Further Reading

Pitt investigators to lead $15 million federal initiative to manage breathing disorder clinical trials

Unique molecule can bind HIV-infected cells to killer T cells

The Center for Bariatric Surgery receives MBSAQIP accreditation for safe, high-quality bariatric patient care

Mylan releases generic version of Invega in the U.S.

Investment in radiotherapy services could save lives, boost economy in developing countries

New Kaiser Permanente study finds small decline in obesity rates among young people in Southern California

TSRI scientists awarded grant from Gates Foundation to develop revolutionary alternative HIV/AIDS vaccine

Mylan releases Fluvastatin Sodium Extended-release Tablets in the U.S.

Study shows fear and stigma are major factors that contribute to spread of AIDS, Ebola

Benitec Biopharma initiates new site for ongoing Phase 1/2a TT-034 trial for hepatitis C

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

A Day with HIV: A new initiative to tackle stigma, discrimination against HIV patients

UNITAID, EGPAF launch new initiative to scale up HIV diagnosis among newborns in African countries

A growing number of deaths attributed to avoidable risk factors

High blood pressure, smoking, and poor dietary habits are greatest risk factors for death

Psychosis, hepatitis C infection are greatest risk factors for mortality in marginalized Vancouver residents

Three drug-like compounds may offer better odds of survival to patients with prostate cancer, find SMU researchers

Mylan releases generic version of Yasmin Tablets in the U.S.

Cipla enters into definitive agreements to acquire two US-based companies

World leaders meet at World Hepatitis Summit to discuss prevention strategies for viral hepatitis

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News